Position in ABBV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$14,420,984
-$1,799,420 QoQ
Shares Held
57,308
-23.2% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#755
of 4,153 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AIA Group Ltd holds $257,927,168 across 9 Drug Manufacturers - General names. ABBV ranks #5 (5.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
313,964 | $79,737,436 | |
| 2 | LLY |
ELI LILLY & Co
|
56,816 | $68,146,820 | |
| 3 | MRK |
Merck & Co., Inc.
|
449,725 | $57,789,662 | |
| 4 | PFE |
Pfizer Inc
|
638,590 | $15,377,247 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
57,308 | $14,420,984 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
149,569 | $8,618,164 | |
| 7 | AMGN |
Amgen Inc
|
21,029 | $7,615,020 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
39,764 | $5,023,783 |
All Filings in ABBV
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,420,984 | 57,308 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $16,220,404 | 74,580 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $13,804,680 | 60,417 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $6,213,838 | 26,837 | Shares | Defined | 2025-12-18 | |
| 2025-06-30 | $2,142,426 | 11,542 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $4,992,442 | 23,828 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $4,373,907 | 24,614 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $7,321,176 | 37,073 | Shares | Defined | 2024-10-31 | |
| 2024-06-30 | $8,221,639 | 47,934 | Shares | Defined | 2024-07-31 | |
| 2024-03-31 | $8,011,489 | 43,995 | Shares | Defined | 2024-05-06 | |
| 2023-12-31 | $1,813,149 | 11,700 | Shares | Defined | 2024-01-31 | |
| 2023-09-30 | $1,222,441 | 8,201 | Shares | Defined | 2023-11-01 | |
| 2023-03-31 | $4,483,237 | 28,131 | Shares | Defined | 2023-04-28 | |
| 2022-12-31 | $5,184,772 | 32,082 | Shares | Defined | 2023-01-31 | |
| 2022-09-30 | $2,259,156 | 16,833 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $5,115,850 | 33,402 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $4,490,933 | 27,703 | Shares | Defined | 2022-05-06 | |
| 2021-12-31 | $3,971,688 | 29,333 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $813,555 | 7,542 | Shares | Defined | 2021-11-05 | |
| 2021-06-30 | $1,607,936 | 14,275 | Shares | Defined | 2021-08-03 | |
| 2021-03-31 | $1,177,325 | 10,879 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $686,295 | 6,405 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||